Zhao Xiaobin, Courtney James M, Yin Hua Q, West Robin H, Lowe G D O
Bioengineering Unit, University of Strathclyde, Glasgow, UK.
J Mater Sci Mater Med. 2008 Feb;19(2):713-9. doi: 10.1007/s10856-007-3191-6. Epub 2007 Jul 10.
Surface modification of plasticised poly (vinyl chloride) (PVC), with di-(2-ethylhexyl) phthalate (DEHP) as plasticiser, for the improvement of blood compatibility in potential clinical use such as cardiopulmonary bypass was achieved by heparinisation. The influence of surface modification on blood compatibility was assessed in terms of the influence on fibrinogen and factor XII adsorption in vitro, and the generation of thrombin-antithrombin III complex (TAT) and the complement component C3a, in vitro and ex vivo. Electron spectroscopy for chemical analysis (ESCA) was used to characterise the heparinised surface in order to correlate the surface properties with the blood response. Results indicate that at the plasticised PVC surface there is a higher content of heparin than that of the PVC and the DEHP content is lower than that present at the surface of standard plasticised PVC. The blood compatibility assessment confirms the importance of surface modification for the improvement of blood compatibility.
以邻苯二甲酸二(2-乙基己基)酯(DEHP)作为增塑剂的增塑聚氯乙烯(PVC),通过肝素化处理实现表面改性,以改善其在体外循环等潜在临床应用中的血液相容性。通过评估表面改性对体外纤维蛋白原和因子Ⅻ吸附的影响,以及体外和离体条件下凝血酶 - 抗凝血酶Ⅲ复合物(TAT)和补体成分C3a的生成,来评价表面改性对血液相容性的影响。利用化学分析电子能谱(ESCA)对肝素化表面进行表征,以便将表面性质与血液反应相关联。结果表明,在增塑PVC表面,肝素含量高于PVC,且DEHP含量低于标准增塑PVC表面的含量。血液相容性评估证实了表面改性对改善血液相容性的重要性。